Scientific Reports: Fire ant venom could treat psoriasis

In trials on mice at the Emory University School of Medicine, Atlanta, the new cream was showed to reduce skin thickening and inflammation - both are typical features of the incurable disorder.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Fabio Casciano, Paolo D. Pigatto, Paola Secchiero, Roberto Gambari, Eva Reali
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
The FDA delivered a significant blow to Valeant this week, denying approval for a treatment the company had hoped would be a one of its top products in the coming years.
Source: - Category: Pharmaceuticals Source Type: news
We describe to our knowledge the first case of paradoxical PPP u nder ustekinumab in a patient with no known underlying psoriasis.
Source: Rheumatology International - Category: Rheumatology Source Type: research
ABSTRACT Purpose: We aimed to report the ocular manifestations observed in patients with psoriasis. Methods: Patients were included and referred to our ophthalmology clinic from dermatology clinics of Universidade do Estado do Par á between October 2013 and August 2014. Clinical interviews were conducted to identify relevant epidemiological data, clinical features, and treatment details, and data were recorded using the same protocol. Subsequent dermatological examinations were performed and disease severity was rated using the Psoriasis Area and Severity Index and the Dermatological Life Quality Index. Complete eye...
Source: Arquivos Brasileiros de Oftalmologia - Category: Opthalmology Source Type: research
CONCLUSIONS: Although mast cells are mediators of pruritus in many cutaneous diseases, our findings support that psoriatic pruritus is a complex disorder with multifactorial, complex pathophysiology, involving pruritogenic mediators others than mast cells.
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
CONCLUSION: Tazarotene gel significantly enhances the therapeutic efficacy of NB-UVB irradiation with faster clearance and without serious side effects.
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
We describe the case of a 65-year-old male patient with chronic psoriasis who presents an exacerbation of his condition over a period of two weeks. Because of the severity of his case and subsequent need for systemic therapy, human immunodeficiency virus enzyme immunoassay was performed and tested positive. He thus began antiretroviral therapy combined with acitretin, showing good clinical response after 8 weeks of treatment. There is little evidence regarding the management of erythrodermic psoriasis associated with HIV infection, so antiretroviral therapy and systemic retinoid remain as the first-line treatment.
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
We report the use of dermoscopy as a diagnostic aid in a case of tinea manuum. The dermoscopic clue turned out to be the presence of whitish scaling located mainly in the furrows. This aspect has never been seen in other keratodermas and therefore can be considered as a useful finding to assist in the recognition of tinea manuum.
Source: Anais Brasileiros de Dermatologia - Category: Dermatology Source Type: research
(Reuters) - Valeant Pharmaceuticals International Inc's plaque psoriasis treatment did not get approval from U.S. health regulators, a set back for the company which had high hopes for the lotion.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Drugmaker's shares slide as regulators decline to approve a lotion for common skin condition
Source: Health News: - Category: Consumer Health News Source Type: news
More News: Health | Psoriasis | Skin